Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Angewandte Chemie (International Ed. in English)
|
March 6, 2025
Perovskite-Coupled NIR Organic Hybrid Solar Cells Achieving an 84.2% Fill Factor and a 25.2% Efficiency: A Comprehensive Mechanistic Exploration
Chieh-Ming Hung, Chia-Jen Chih, Kuo-Hsiu Huang, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 13, 2019
Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience
Johan Chan, Shi Yin Yap, Yian Ching Fong, et al.
Journal of Medical Virology
|
November 15, 2019
Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B
Sheng Shen, Grace L-H Wong, Zhe Kuang, et al.
Journal of the American Chemical Society
|
May 29, 2026
Emissive Colloidal GaAs Quantum Dots
Jun Hyuk Chang, Danial Zangeneh, Heng-Chi Chu, et al.
Plos One
|
September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform
Yoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Journal of Hepatology
|
December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Journal of Gastroenterology and Hepatology
|
March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis B
Heng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Journal of Viral Hepatitis
|
September 7, 2018
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up
Margo J H van Campenhout, Willem Pieter Brouwer, Qing Xie, et al.
Hepatology (Baltimore, Md.)
|
June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
George V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Angewandte Chemie (International Ed. in English)
|
March 6, 2025
Perovskite-Coupled NIR Organic Hybrid Solar Cells Achieving an 84.2% Fill Factor and a 25.2% Efficiency: A Comprehensive Mechanistic Exploration
Chieh-Ming Hung, Chia-Jen Chih, Kuo-Hsiu Huang, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 13, 2019
Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience
Johan Chan, Shi Yin Yap, Yian Ching Fong, et al.
Journal of Medical Virology
|
November 15, 2019
Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B
Sheng Shen, Grace L-H Wong, Zhe Kuang, et al.
Journal of the American Chemical Society
|
May 29, 2026
Emissive Colloidal GaAs Quantum Dots
Jun Hyuk Chang, Danial Zangeneh, Heng-Chi Chu, et al.
Plos One
|
September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform
Yoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Journal of Hepatology
|
December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Journal of Gastroenterology and Hepatology
|
March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis B
Heng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Journal of Viral Hepatitis
|
September 7, 2018
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up
Margo J H van Campenhout, Willem Pieter Brouwer, Qing Xie, et al.
Hepatology (Baltimore, Md.)
|
June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
George V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Page
of 21